MedCap AB (publ)

OM:MCAP Rapporto sulle azioni

Cap. di mercato: SEK 8.2b

MedCap Gestione

Gestione criteri di controllo 3/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Anders Dahlberg

Amministratore delegato

SEK 6.6m

Compenso totale

Percentuale dello stipendio del CEO45.3%
Mandato del CEO4yrs
Proprietà del CEO0.1%
Durata media del management4yrs
Durata media del Consiglio di amministrazione2.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

MedCap AB (publ)'s (STO:MCAP) Earnings Haven't Escaped The Attention Of Investors

Oct 18
MedCap AB (publ)'s (STO:MCAP) Earnings Haven't Escaped The Attention Of Investors

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Jun 06
Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

May 21
MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

May 04
Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15
MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

Dec 21
Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

May 06
Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

Nov 23
These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Sep 21
We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

Apr 29
Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Feb 01
MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Aug 03
Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

May 27
Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Apr 07
Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Mar 15
Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

Feb 26
Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

MedCap (STO:MCAP) Could Easily Take On More Debt

Feb 08
MedCap (STO:MCAP) Could Easily Take On More Debt

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Jan 22
Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Jan 07
Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

Dec 22
MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Dec 08
If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Nov 23
Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Anders Dahlberg rispetto agli utili di MedCap?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

SEK 228m

Jun 30 2024n/an/a

SEK 214m

Mar 31 2024n/an/a

SEK 203m

Dec 31 2023SEK 7mSEK 3m

SEK 172m

Sep 30 2023n/an/a

SEK 150m

Jun 30 2023n/an/a

SEK 149m

Mar 31 2023n/an/a

SEK 123m

Dec 31 2022SEK 7mSEK 3m

SEK 118m

Sep 30 2022n/an/a

SEK 118m

Jun 30 2022n/an/a

SEK 107m

Mar 31 2022n/an/a

SEK 102m

Dec 31 2021SEK 6mSEK 3m

SEK 97m

Compensazione vs Mercato: Anders's total compensation ($USD610.95K) is about average for companies of similar size in the Swedish market ($USD740.54K).

Compensazione vs guadagni: Anders's compensation has been consistent with company performance over the past year.


AMMINISTRATORE DELEGATO

Anders Dahlberg (48 yo)

4yrs

Mandato

SEK 6,567,000

Compensazione

Mr. Anders Dahlberg serves as the Chief Executive Officer at MedCap AB, since November 1, 2020. Previously he served as Partner of Applied Value AB till August 2017, where he also had been a Chairman. Mr....


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Anders Dahlberg
Chief Executive Officer4yrsSEK 6.57m0.14%
SEK 11.1m
Kristina Ekblad
Chief Financial Officer4.5yrsNessun datoNessun dato
Lars Ångman
Investment Manager4yrsNessun dato0.034%
SEK 2.8m

4.0yrs

Durata media

Gestione esperta: MCAP's management team is considered experienced (4 years average tenure).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Karl Tobieson
Chairman2.9yrsSEK 425.00k1.23%
SEK 100.9m
Torgny Svensson
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Lena Söderström
Independent Director2.5yrsSEK 175.00kNessun dato
Karl-Olov Fagerström
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Staffan Nilsson
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Gunnar Kratz
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Holland Cheng
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Otto Ankarcrona
Independent Director1.8yrsSEK 175.00kNessun dato
David Jern
Independent Director2.9yrsSEK 175.00kNessun dato
Malin Enarson
Independent Director1.8yrsSEK 175.00kNessun dato
Anna Torner
Independent Director2.5yrsSEK 175.00kNessun dato

2.5yrs

Durata media

53yo

Età media

Consiglio di amministrazione esperto: MCAP's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.